New technologies and patient choice. A lesson from the chymopapain experience.
Brushwood
D B
DB
Kaufman
H H
HH
Trumbull
W H
WH
D002917:Chymopapain / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D033161:Government Regulation; D006801:Humans; D007404:Intervertebral Disc Chemolysis; D010344:Patient Advocacy; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
D002917:Chymopapain